CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10 | ¥24 | ¥34 | ¥82 |
| - Cash | ¥5 | ¥4 | ¥5 | ¥3 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥5 | ¥19 | ¥29 | ¥79 |
| Revenue | ¥4 | ¥4 | ¥5 | ¥4 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Gross Profit | ¥2 | ¥2 | ¥3 | ¥3 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| EBITDA | ¥0 | ¥0 | ¥1 | ¥2 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |
| Net Income | ¥0 | ¥0 | ¥1 | ¥1 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| % Growth | -95.5% | -75% | -9.5% | – |
| Operating Cash Flow | ¥0 | ¥1 | ¥1 | ¥1 |
| Capital Expenditures | -¥0 | -¥1 | -¥0 | -¥0 |
| Free Cash Flow | ¥0 | ¥0 | ¥0 | ¥1 |